These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28028685)

  • 1. RAPID3 scores and hand outcome measurements in RA patients: a preliminary study.
    Qorolli M; Hundozi-Hysenaj H; Rexhepi S; Rehxepi B; Grazio S
    Clin Rheumatol; 2017 Jun; 36(6):1379-1385. PubMed ID: 28028685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.
    Qorolli M; Rexhepi B; Rexhepi S; Mustapić M; Doko I; Grazio S
    Rheumatol Int; 2019 May; 39(5):827-834. PubMed ID: 30847560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
    Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
    Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
    Pincus T; Swearingen CJ; Bergman M; Yazici Y
    J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
    Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
    Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hand function tests are important and sensitive tools for assessment of treatment response in patients with rheumatoid arthritis.
    Eberhardt K; Sandqvist G; Geborek P
    Scand J Rheumatol; 2008; 37(2):109-12. PubMed ID: 18415767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care?
    Pincus T
    Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease activity dynamics in rheumatoid arthritis: patients' self-assessment of disease activity via WebApp.
    Walker UA; Mueller RB; Jaeger VK; Theiler R; Forster A; Dufner P; Ganz F; Kyburz D
    Rheumatology (Oxford); 2017 Oct; 56(10):1707-1712. PubMed ID: 28957553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
    Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
    Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort.
    Castrejón I; Dougados M; Combe B; Guillemin F; Fautrel B; Pincus T
    J Rheumatol; 2013 Apr; 40(4):386-93. PubMed ID: 23378463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAPID3, an index to assess and monitor patients with rheumatoid arthritis, without formal joint counts: similar results to DAS28 and CDAI in clinical trials and clinical care.
    Pincus T; Yazici Y; Bergman MJ
    Rheum Dis Clin North Am; 2009 Nov; 35(4):773-8, viii. PubMed ID: 19962621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time to score quantitative rheumatoid arthritis measures: 28-Joint Count, Disease Activity Score, Health Assessment Questionnaire (HAQ), Multidimensional HAQ (MDHAQ), and Routine Assessment of Patient Index Data (RAPID) scores.
    Yazici Y; Bergman M; Pincus T
    J Rheumatol; 2008 Apr; 35(4):603-9. PubMed ID: 18322993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease activity, handgrip strengths, and hand dexterity in patients with rheumatoid arthritis.
    Palamar D; Er G; Terlemez R; Ustun I; Can G; Saridogan M
    Clin Rheumatol; 2017 Oct; 36(10):2201-2208. PubMed ID: 28721628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hand function and activity limitation according to health assessment questionnaire in patients with rheumatoid arthritis and healthy referents: 5-year followup of predictors of activity limitation (The Swedish TIRA Project).
    Björk MA; Thyberg IS; Skogh T; Gerdle BU
    J Rheumatol; 2007 Feb; 34(2):296-302. PubMed ID: 17299837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of self-report questionnaires for assessing rheumatoid arthritis activity: a cross-sectional study of RAPID3 and RADAI5 and flare detection in 200 patients.
    Bossert M; Prati C; Vidal C; Bongain S; Toussirot E; Wendling D
    Joint Bone Spine; 2012 Jan; 79(1):57-62. PubMed ID: 21550283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAI.
    Yokogawa N; Kaneko T; Nagai Y; Nunokawa T; Sawaki T; Shiroto K; Shimada K; Sugii S
    Mod Rheumatol; 2015 Mar; 25(2):264-9. PubMed ID: 25156777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
    Pincus T; Hines P; Bergman MJ; Yazici Y; Rosenblatt LC; MacLean R
    J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hand disability and related variables in patients with rheumatoid arthritis.
    Bodur H; Yilmaz O; Keskin D
    Rheumatol Int; 2006 Apr; 26(6):541-4. PubMed ID: 16079993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures.
    Pincus T; Bergman MJ; Yazici Y; Hines P; Raghupathi K; Maclean R
    Rheumatology (Oxford); 2008 Mar; 47(3):345-9. PubMed ID: 18238788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.
    Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Zueger P; Ali M; Strand V
    Rheumatol Ther; 2022 Dec; 9(6):1517-1529. PubMed ID: 36125701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.